The Institute of Cancer and Crisis (ICC)

What The Institute of Cancer and Crisis (ICC) does

The Institute of Cancer and Crisis (ICC) is an independent not-for-profit research organization founded in 2021 in Yerevan, Armenia, with the foundational support of the City of Smile Charitable Foundation. Its mission is to ensure that cancer patients in crisis-affected settings — including conflict zones and post-war regions — receive appropriate prevention, diagnosis, and care. ICC produces peer-reviewed research (including publications in The Lancet and Nature Reviews Cancer), runs a multi-country research program covering Armenia, Egypt, Iraq, and Georgia, hosts expert interview content through the 'Cancer and Crisis Talks' video series, and convened the first Global Summit on War and Cancer with OncoDaily in December 2023. The organization does not develop or sell software products and has no proprietary technology platform disclosed.

ICC is governed by a board of directors and advisors drawing from Queen's University Belfast, King's College London, NYU, Yerevan State Medical University, the Association of European Cancer Leagues, and the WHO Country Office in Armenia, providing academic and policy credibility. Its core operating team is small — approximately five employees, including an Executive Director, research associates, and project coordinators — supplemented by the unpaid board and academic affiliates. ICC does not operate on a commercial revenue model; it is funded through charitable grants and donations, with City of Smile Charitable Foundation as its founding supporter. There is no disclosed revenue, funding total, or operating budget in public materials.

Name

The Institute of Cancer and Crisis (ICC)

Legal name

Institute of Cancer and Crisis (ICC)

Website

https://cancerandcrisis.org

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

The Institute of Cancer and Crisis (ICC) is an Armenia-based not-for-profit, founded in 2021, that conducts research, publishes in top medical journals, and convenes global experts to improve cancer care for patients living in conflict-affected and humanitarian crisis settings.

Ownership category

akta.pro rank

Product category

Public Health Research and Policy Advocacy

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

akta.pro secondary industries

Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM), Community Health, Health Promotion & Behavior Change (SBCC) (BPADAIAL), Health Systems Strengthening & Universal Health Coverage (UHC) Partnerships (HLAJAOAL)

Keywords

• Cancer care research
• Humanitarian oncology
• Global public health
• Health policy advocacy
• Crisis-affected populations

Headquarters

HQ city

Yerevan

HQ country

Armenia

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Not-for-profit funding model: The Institute of Cancer and Crisis is an independent not-for-profit organization established with the support of the City of Smile Charitable Foundation in 2021. Revenue model is based on charitable funding, grants, and donations rather than commercial revenue streams.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

The Institute of Cancer and Crisis (ICC) is a not-for-profit research and policy organization that produces peer-reviewed research, expert video content, and global convenings focused on improving cancer prevention, care, and diagnosis for patients in conflict-affected and crisis settings. Its main outputs include published research manifestos in The Lancet and Nature Reviews Cancer, the "Cancer and Crisis Talks" expert interview series, and the Global Summit on War and Cancer. ICC does not sell commercial products or services; it disseminates research findings and policy recommendations to healthcare professionals, policymakers, and patient advocates globally.

Product overview

The Institute of Cancer and Crisis (ICC) is a not-for-profit research organization established in 2021, not a traditional product company. Its primary offerings consist of research publications, expert knowledge content (Cancer and Crisis Talks video series), and an annual conference (Global Summit on War and Cancer). The organization does not develop or sell software products but instead produces research-driven content aimed at improving cancer care in conflict-affected regions.

Differentiator

Problem solved

Functional benefit

Products and services

• ICC Publications (Manifestos and Research Papers)

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered core and minor.

• OncoDailycoreStrategic or Co-development Partner · 14 December 2023OncoDaily co-organized the first Global Summit on War and Cancer with ICC on December 14-16, 2023. Richard Sullivan serves as Editor-in-chief of OncoDaily, indicating a close working relationship between the organizations.
• Yerevan State Medical UniversityminorStrategic or Co-development PartnerICC has connections to Yerevan State Medical University through board members (Gevorg Tamamyan is Professor of Hematology and Pediatric Oncology) and team members (Mariam Khachatryan is Clinical Resident at the Department of Oncology).
• Queen's University BelfastminorStrategic or Co-development PartnerICC Research Lead Mark Lawler is Associate Pro-vice-chancellor and Professor of Digital Health at Queen's University Belfast, providing academic and research collaboration ties.
• King's College LondonminorStrategic or Co-development PartnerRichard Sullivan serves as Director of the New Kings Institute of Cancer Policy and Professor of Cancer Policy and Global Health at King's College London, providing policy expertise and institutional collaboration.
• New York UniversityminorStrategic or Co-development PartnerRalph J. DiClemente serves as Chair of the Department of Social and Behavioral Sciences and Associate Dean of Public Health Innovation at New York University, contributing social and behavioral sciences expertise.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• OncoDaily: OncoDaily is an oncology media and news platform that co-organized the Global Summit on War and Cancer with ICC and shares editorial leadership with ICC board members. Directly comparable as an oncology media/convening entity, with overlapping leadership and joint flagship event.
• International Society of Paediatric Oncology (SIOP): SIOP is a global professional society for pediatric oncology, of which ICC Board Chairman Gevorg Tamamyan is President of the SIOP Asia Continental Branch. Comparable as a global cancer professional society, though SIOP focuses on pediatric oncology while ICC is broader across cancer types and crisis contexts.
• Union for International Cancer Control (UICC): UICC is the largest global membership organization dedicated to cancer control, convening summits and publishing policy. ICC is directly comparable as a cancer-focused policy/convening organization, though ICC's narrower conflict-crisis framing distinguishes it.
• King's Institute of Cancer Policy: Led by ICC board member Richard Sullivan at King's College London, the King's Institute of Cancer Policy conducts global research on cancer policy. Directly comparable as a cancer policy and global health research entity with overlapping leadership and topical focus.

Broad incumbents

• International Committee of the Red Cross (ICRC): ICRC provides healthcare and protection in armed conflict and is a leading voice on medical neutrality. Comparable to ICC because both focus on healthcare access in conflict settings, though ICRC operates across all medical needs, not just cancer.
• Médecins Sans Frontières (MSF): MSF delivers healthcare in conflict and crisis zones globally, including cancer care components. Comparable to ICC because both operate at the intersection of healthcare delivery and humanitarian crisis, though MSF is orders of magnitude larger and broader in scope.
• International Agency for Research on Cancer (IARC/WHO): IARC is the WHO's specialized cancer research agency producing global cancer statistics and research. Comparable to ICC for its cancer research and global health convening mandate, though IARC operates at a vastly larger scale and is government-backed.
• American Cancer Society (ACS): ACS is one of the largest global cancer voluntary health organizations, funding research and convening on cancer control. Comparable to ICC as a global cancer-focused non-profit producing research and convening, though ACS is US-centric and far larger.

Others

• City of Smile Charitable Foundation: City of Smile is the Armenian charitable foundation that founded and continues to support ICC. It is a peer in the cancer-patient support space in Armenia and overlapping in mission, while being structurally ICC's founding supporter rather than a competitor.
• Lancet Oncology: Lancet Oncology is the leading peer-reviewed oncology journal that publishes high-impact cancer research including ICC-affiliated work. Relevant as the publication venue for ICC's cancer policy and crisis-oncology research, and a channel partner rather than direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks1 record

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/the-institute-of-cancer-and-crisis

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Institute of Cancer and Crisis (ICC)